Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01950703
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
C12 | 2-(1-AMINO-2-HYDROXYPROPYL)-4-(4- HYDROXYBENZYL)-1-(2-OXOETHYL)-1H- IMIDAZOL-5-OLATE | A | 2FZU | 0.71 | |
FRC | 1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}- 1H-IMIDAZONE-4-CARBOXAMIDE | A | 1V7A | 0.8 | |
BZG | 6-(BENZYLOXY)-9-(2-DEOXY-5-O-PHOSPHONO- BETA-D-ERYTHRO-PENTOFURANOSYL)- 9H-PURIN-2-AMINE | A,P,T | 2JEF | 0.73 | |
BZG | 6-(BENZYLOXY)-9-(2-DEOXY-5-O-PHOSPHONO- BETA-D-ERYTHRO-PENTOFURANOSYL)- 9H-PURIN-2-AMINE | A,P,T | 2JEG | 0.73 | |
BZG | 6-(BENZYLOXY)-9-(2-DEOXY-5-O-PHOSPHONO- BETA-D-ERYTHRO-PENTOFURANOSYL)- 9H-PURIN-2-AMINE | A,T | 2JEI | 0.73 | |
BZG | 6-(BENZYLOXY)-9-(2-DEOXY-5-O-PHOSPHONO- BETA-D-ERYTHRO-PENTOFURANOSYL)- 9H-PURIN-2-AMINE | A,P,T | 2JEJ | 0.73 | |
DZ8 | 2-FLUORO-8-[(6-IODO-1,3-BENZODIOXOL- 5-YL)METHYL]-9-[3-(ISOPROPYLAMINO)PROPYL]- 9H-PURIN-6-AMINE | A | 2H55 | 0.72 | |
GDV | (5R,6R,7R,8S)-8-(ACETYLAMINO)-6,7- DIHYDROXY-5-(HYDROXYMETHYL)-N-PHENYL- 1,5,6,7,8,8A-HEXAHYDROIMIDAZO[1,2- A]PYRIDINE-2-CARBOXAMIDE | A | 2J47 | 0.7 | |
3IG | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN- 5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO- 4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE | A,B | 2G1R | 0.71 | |
3FP | (2R)-1-(DIMETHYLAMINO)-3-{4-[(6- {[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN- 4-YL)AMINO]PHENOXY}PROPAN-2-OL | A | 1V1K | 0.71 | |
656 | 2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL- 2-YL}-6-ISOBUTOXYBENZENOLATE | A | 1O2K | 0.7 | |
656 | 2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL- 2-YL}-6-ISOBUTOXYBENZENOLATE | A | 1O2J | 0.7 | |
G96 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(2R)-2-amino- 3-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B,C,D,E,F | 3E8C | 0.72 | |
G96 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(2R)-2-amino- 3-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B | 3E88 | 0.72 | |
GSR | A | 1AF1 | 0.73 | ||
090 | N-(2,3-DIHYDRO-7,8-DIMETHOXYIMIDAZO[1,2- C] QUINAZOLIN-5-YL)NICOTINAMIDE | A | 2CHX | 0.7 | |
CK9 | 2-{[(2-{[(1R)-1-(HYDROXYMETHYL)PROPYL]AMINO}- 9-ISOPROPYL-9H-PURIN-6-YL)AMINO]METHYL}PHENOL | X | 2A0C | 0.74 | |
5IG | 6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN- 5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL- 2H-1,4-BENZOXAZIN-3(4H)-ONE | A,B | 2G1Y | 0.7 | |
1PM | methyl (3S)-3-{2-[(1,3-benzodioxol- 5-ylmethyl)amino]-2-oxoethyl}-4- [2-(1H-imidazol-1-yl)pyrimidin- 4-yl]piperazine-1-carboxylate | A | 1DD7 | 0.73 | |
GRD | benzyl (S)-1-((2S,3S)-1-(3-(6-amino- 9H-purin-9-yl)propylamino)-2-hydroxy- 1-oxopentan-3-ylamino)-4-methyl- 1-oxopentan-2-ylcarbamate | A | 2R9C | 0.76 | |
G98 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(1S)-3-amino- 1-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B,E,I,L,P | 3E8E | 0.73 | |
G98 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(1S)-3-amino- 1-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B | 3E8D | 0.73 | |
CL4 | N-{3-[5-(6-AMINO-PURIN-9-YL)-3,4- DIHYDROXY-TETRAHYDRO-FURAN-2-YL]- ALLYL}-2,3-DIHYDROXY-5-NITRO-BENZAMIDE | A | 1JR4 | 0.7 | |
228 | N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]- 1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN- 4-YL]-D-PROLINAMIDE | A | 2ORO | 0.73 | |
4CA | 4-HYDROXYBENZYL COENZYME A | A | 1LO8 | 0.71 | |
4CA | 4-HYDROXYBENZYL COENZYME A | A | 1Q4U | 0.71 | |
FRE | FERULOYL COENZYME A | A,B,C,D | 1SUI | 0.72 |